From Queen Elizabeth Hospital for Children, London (RECEIVED FOR PUBLICATION NOVEMBER 20, 1962) Although essential fructosuria has been known for 70 years and has been recognized as an inborn error of metabolism for more than 20 years (Lasker, 1941) , it is only recently that a second metabolic anomaly involving fructose has been described by Froesch, Prader, Labhart, Stuber and Wolf (1957) . These authors recorded four affected (two children and two adults) and three probably affected members of a large family in which intermarriage had been frequent. This condition of fructose intolerance, although similar in some respects to essential fructosuria, differed in that ingestion of fructose or fructose-containing foods caused a sharp and prolonged fall in the blood glucose level accompanied by the clinical symptoms of severe hypoglycaemia. The continued ingestion of fructose in infancy could result in retarded growth and mental development.
Subsequently, Froesch, Prader, Wolf and Labhart (1959) suggested that, in essential fructosuria, the metabolic anomaly lay in a deficiency of the hepatic fructokinase ( Fig. 1 ) which converts the fructose to fructose-l -phosphate, whereas in fructose intolerance there was an absence or deficiency of fructose-lphosphate aldolase, cleaving fructose-l-phosphate to glyceraldehyde and dihydroxyacetone phosphate (Fig. 1 ). This hypothesis was based mainly on the prolonged fall in serum phosphate which occurred on fructose administration, indicating that the conversion of fructose to fructose-1-phosphate by the specific fructokinase had proceeded normally, with accumulation of the phosphate in the cell.
The clear recognition of this syndrome has been rapidly followed by several further reports of cases (Wolf, Zschocke, Wedemeyer and Hubner, 1959; Dormandy and Porter, 1961; Dubois, Loeb, Ooms, Gillet, Bartman and Champenois, 1961; Jeune, Planson, Cotte, Bonnefoy, Nivelon and Skosowsky, 1961; Nikkilii, Somersalo, Pitkanen and Perheentupa, 1962) . In four instances, one other member of the family was affected by the same metabolic abnormality but less severely.
We now record three further examples of this condition, two sibs of one family and the third in an unrelated family. The younger of the two sibs was admitted to hospital at 7 weeks of age because of reluctance to take feeds, lethargy and severe weight loss. The presence of fructose in the urine on many occasions, so long as the patient was on feeds containing sucrose, led to the diagnosis. Examination of the rest of the family revealed another affected child, normal in intelligence and growth.
The investigations described in this article afford further evidence for the suggested underlying metabolic anomaly in this condition and also show the clinical and biochemical similarity between it and galactosaemia, for which reason we prefer to call it fructosaemia, rather than fructose intolerance. As these cases were discovered within a period of a few months of each other, it is likely that the condition is more common than was at first thought and because it may lead to mental and physical retardation and underdevelopment, it is important that it should be recognized as early as possible, since it is easily treated. Th estimations of the level of plasma and urinarv reafter. She constituents, including amino acids, phosphorus and 16 lb. 1 oz. magnesium, and of total blood sugar, glucose and fructhe recorded tose, were performed according to the standard microthought then methods in use in this laboratory. to sit up by
The serum and liver aldolase levels were deternined by a modification of the method of Sibley and Lehninger mal physical (1949) and liver fructokinase by a modification of the sol and has method of Hers and Joassin (1961) . Details of the Her mother enzyme methods will be published at a later date. Biochemical Investigations and Liver Function Tests Case 1. Apart from a low carbon dioxide combining capacity and raised plasma chloride, the electrolytes were within normal limits. On admission the serum protein was low, presumably accounting for the low plasma calcium found. Plasma phosphorus was usually low, and on one occasion when she was severely ill it was less than 1 0 mg. per 100 ml. The significance of this finding is discussed below. The alkaline phosphatase initially was within normal limits, but later the level rose to 58 K.A. units per 100 ml., probably indicating a moderately severe impairment of liver function. After sucrose had been excluded from the feeds, the levels returned to normal values within a few weeks.
In the early stages only the serum glutamic-oxaloacetic transaminase (SGOT) was above the normal level. Later, when she was more severely ill, both the serum glutamic-pyruvic transaminase (SGPT) and SGOT were increased, afterwards falling to the initial levels. Two days after a test dose of fructose was administered, the levels again rose, returning to the earlier levels a week after the fructose tolerance test (see Table 1 ).
Urinary and Serum Amino Acids. Paper chromatography of the urine, performed on a number of occasions when the patient was between 2 and 4 months of age, showed a generalized increase in the excretion of the amino acids. The proportion of urinary amino acid nitrogen to total urinary nitrogen fluctuated between 3-7% and 17-3%, compared with a normal level of up to 3% for an infant of this age. The amino acid excretion fell to less than 3% within a fortnight of the exclusion of sucrose from the feeds. On the day after the fructose tolerance test, the proportion of amino acid nitrogen to total nitrogen rose to nearly 5%, dropping to half this value two days later.
The serum amino-nitrogen levels determined on three occasions were 8 * 3 mg., 4-7 mg. and 3 * 5 mg. per 100 ml., the first value coinciding with the greatest aminoaciduria found. The observation of a high amino acid nitrogen level in the plasma suggests that this could be classified as an overflow aminoaciduria (Dent, 1957) such as would occur in severe hepatic disease, but it does not apply to those times when the level of amino acids in the serum was within normal limits. Cusworth, Dent and Flynn (1955) aciduria is of renal type, but Van Geffel, Devriendt, Dustin, Vis and Loeb (1959) found high plasma amino acid levels associated with hyperaminoaciduria in a case of galactosaemia with marked hepatic disturbance and concluded that a hepatic, as well as a renal factor was, involved. Our findings suggest that a similar combination of factors is involved in fructosaemia. Magnesium. The serum magnesium levels were estimated on a number of occasions before the first fructose tolerance test. The levels ranged between 1 0 and 1-8 mg. per 100 ml. (0-83 to 1 08 mEq/litre); the significance of these low levels and the alterations during the tolerance tests is discussed below.
Case 3. The plasma electrolytes were within normal limits except for the carbon dioxide capacity which showed a moderate diminution. Initially the serum transaminases were moderately elevated. Six weeks after a fructose-free diet had been instituted, the transaminases had returned to normal levels, despite two fructose tolerance tests carried out in the intervening period (Table 1) . Other liver function tests were normal.
As in Case 1, the urinary amino acids were initially greatly increased (amino acid nitrogen 21-3% of the total nitrogen), but five weeks after the commencement of treatment the urinary amino acid excretion fell to normal values (amino acid nitrogen 1% of the total urinary nitrogen).
Carbohydrate Metabolism Case 1. Paper chromatography usually revealed the presence of fructose during the period before treatment and, on one or two occasions, traces of glucose and galactose.
Glucose Tolerance Test. This was performed about three weeks after fructose-containing foods had been eliminated from the feeds and was found to be normal. The glycogen stores were judged to be normal on the bases of the glucagon test, a rise of 16 mg. per 100 ml. in the blood glucose being noted 30 was still very high two and a half hours later. The fall in the true blood glucose was immediate and severe, dropping to 10 mg. per 100 ml. at the end of 30 minutes, and falling still lower thereafter. Even when the blood fructose level was receding, the blood glucose failed to rise from its extremely low level.
Because it was possible that the low plasma phosphorus and magnesium levels were due to the metabolic anomaly, a second fructose tolerance test was performed after the infant had been on a fructose-free diet for 12 weeks. A smaller loading dose of fructose (2 5 g.) was used in order to avoid too severe a hypoglycaemic effect, and the results are shown in Fig. 3 . The fall in blood glucose was even greater, despite the smaller dose, although the rise in blood fructose was relatively slight. The total blood sugar, as determined by the Folin-Wu method, masked the fall in blood glucose so that the hypoglycaemia would have be-n overlooked if the usual method of estimation of blood sugar had been used. There was also a significant fall in the plasma phosphorus, from an initial level of 4.5 mg. to 2-4 mg. per 100 ml. one hour after the fructose was given, rising again to 3. 3 mg. per 100 ml. at the end of two and a half hours.
This fall was accompanied by a rise in the serum magnesium level from 2 2 mg. to a maximum of 3-1 mg. at one and a half hours, falling to 2 6 mg. per 100 ml. at the end of the test. Hypoglycaemic symptoms were apparent 30 minutes after fructose administration and a convulsion occurred towards the end of the test, responding rapidly to intravenous glucose.
A similar investigation was performed on both parents and the three sibs of Case 1. The result obtained with Case 2, the affected sib, is shown in Fig. 4 . Oral glucose had to be given to avert a hypoglycaemic attack one hour after the fructose had been given. The rise in blood fructose was more marked and so was the fall in blood glucose. The serum phosphorus fell from an initial fasting level of 4-4 mg. to 3 0 mg. at 45 minutes, before rising to 3 9 mg. per 100 ml. at one and threequarter hours. The serum magnesium rose from an initial level of 1-65 mg. to 2-5 mg. per 100 ml. at the end of 30 minutes and fell only slightly thereafter.
The results for the rest of the family were quite normal. As an example, the results from a sib aged 3 years are shown in Fig. 5 . The blood fructose levels did not rise by more than 20 mg. per 100 ml. at the maximum, and in each case there was a rise, not a fall, in the blood glucose and plasma phosphorus. It is also important to note that there appeared to be no significant change in the level of magnesium during the tesc.
Galactose Tolerance Test. This gave a rise in blood galactose levels well within normal limits, while the true blood glucose also rose after administration of the galactose, in contrast to the findings during the fructose tolerance test.
Sorbose Tolerance Test. In view of the close chemical similarity of sorbose and fructose, it was thought worth while to observe the effect of administration of sorbose.
There was a sustained increase in blood sorbose, over 60 mg. per 100 ml. at the maximum, which occurred at least three and a half hours after the initial dose. This suggests some impairment in the ability to metabolize sorbose; however, the true blood glucose rose instead of falling, as happened with fructose.
Case 3. Paper chromatography of the urine, before treatment was instituted, again usually revealed only fiuctose, but on two occasions a fasting specimen of urine showed, in addition to fructose, a small amount of glucose and traces of sucrose and lactose.
Injection of glucagon (100 ,Lg.) gave a normal blood glucose response.
Fructose Tolerance Tests. The result of a loading dose of 6 g. fructose (Fig. 6 ) was similar in all respects to that in Cases I and 2. The rise in plasma magnesium was again very significant, from 2-1 to 2-6 mg. per 100 ml., the highest level being attained two hours after the fructose had been given.
Galactose Tolerance Test. This was within normal limits.
Sorbose Tolerance Test. The result of this test was very similar to that of Case 1 with a rise of over 60 mg. in the blood sorbose level, still sustained at the end of two hours.
Enzyme Studies Serum Aldolase. These levels, using both fructose-lphosphate and fructose-1 :6-diphosphate as substrates, were measured in some cases of infective hepatitis and in Case 1 during the illness and after recovery, as well as in some normals. With fructose-1 :6-diphosphate as substrate, the normal levels found were usually between 5 and 7 units, one unit being 1 ,umole of substrate utilized per minute per litre of serum. Very much higher levels, up to 50 units, were obtained during hepatitis, and these fell as the liver dysfunction receded to the values obtained in normal sera. A similar high level was found in Cases 1 and 3 during the height of the liver dysfunction, 30 and-20 units respectively, compared with their normal values of 6 units.
The low levels of fructose-l-phosphate activity found in normal sera could only be approximately determined by the micromethod used, and were often zero, and usually less than 1 5 units. During hepatitis, high levels were found, up to 40 units, falling as the hepatitis receded. In Cases 1 and 3 the low levels found (less than 1 unit) remained unchanged despite the liver impairment.
Liver Enzymes. The fructokinase and aldolase activities towards both fructose-l -phosphate and fructose-1 :6-diphosphate were estimated in a biopsy specimen of liver within one hour of removal and compared with a fresh specimen similarly obtained from a case of liver dysfunction (Y.G. the main features of the condition from the 16 cases, five males and 11 females, recorded, including the three cases now described, although in some the clinical information is incomplete. Apart from the different hexoses involved, the findings are almost identical with those of galactosaemia with the exception that no cases of cataract have been described in fructosaemia.
The mode of presentation depends on the agegroup. The younger group, usually less than 6 months of age, presents as failure to thrive. The older cases are more usually discovered among the relatives of an affected infant. They are often symptomless, but have a marked aversion to sweet foods, as had our second case. The main factor determining the age at which symptoms appear is the time at which breast-feeding is discontinued. If this ceases early, with a change to artificial milk feeds and added cane sugar, then almost at once there is anorexia, vomiting, lethargy, hypotonia and failure to gain weight. If breast-feeding is maintained until solids are introduced, the infant is usually over 6 months old and able to make a positive rejection of feeds which make him ill. Because of this, weaning from the breast is difficult until it is found that only non-sweet foods are acceptable. It seems likely that the strong aversion to sucrose or fructose-containing foods is a conditioned response, similar to that seen in aversion therapy. It is logical also to assume that the later in life the infant begins to ingest fructose-containing foods, the less severe will be the sequelae. Similarly, in a galactosaemic infant, if for any reason he has refused or been taken off breast or cows' milk, or has diminished milk feeds, the sequelae will be less severe.
Although fructosaemia cannot readily be differentiated from galactosaemia on clinical grounds alone, one feature in the history may point to the correct diagnosis. In fructosaemia, the infant becomes ill when taken off the breast, whereas in galactosaemia, symptoms occur as soon as breast or cows' milk feeding is begun.
The association of failure to thrive with vomiting and anorexia, hepatomegaly and hypoglycaemic attacks, following weaning from the breast, will suggest the diagnosis which is confirmed by the laboratory findings. (Leuthardt, 1957; Hers, 1957) have clarified the metabolic pathway of fructose in the body and its interrelation with glucose (Fig. 1) . In the liver cell, fructose is phosphorylated in the presence of adenosine triphosphate (ATP) and magnesium ions by a specific fructokinase to fructose-l-phosphate, which then undergoes cleavage by an aldolase to a mixture of trioses which are intermediates in the metabolism of glucose. Fructose can also be converted by means of a non-specific hexokinase into fructose-6-phosphate, also a stage in the glycolytic pathway. This can only be of slight importance in the metabolism of fructose, however, owing to the greater affinity of the kinase for glucose, the presence of which in concentrations normally found will inhibit any activity towards fructose. The metabolic pathway for glucose includes the cleavage of fructose-I :6-diphosphate by aldolase to a mixture of trioses. Although Leuthardt, Testa and Wolf (1953) have claimed to demonstrate by chromatographic separation the existence of two specific aldolases acting on fructose-l-phosphate and fructose-l :6-diphosphate respectively, the balance of evidence is against this view. Thus, Peanasky and Lardy (1958) have shown that purified bovine liver aldolase could split both substrates, the affinity for the fructose diphosphate being twice as great as for fructose-l-phosphate. Tung, Ling, Byrne and Lardy (1954) have proved that aldolase from rabbit muscle could also split both substrates, although the activity towards the fructose diphosphate was, in this case, about six times greater than for fructose-l-phosphate. Finally, Hers and Joassin (1961) could not confirm the results of Leuthardt et al. (1953) .
Although a demonstration of the absence or marked diminution of the activity of aldolase in the liver of an affected infant would have afforded the most convincing proof of the correctness of the suggestion of Froesch et al. (1959) , this was not thought justified in Case 1 or Case 2. At first, it was believed that alterations in serum or erythrocyte aldolase might throw some light on the aetiology. Unfortunately, although the enzymatic activity of the aldolase in normal serum or erythrocytes towards fructose-I :6-diphosphate is appreciable, activity to fructose-l-phosphate is either very low or absent. The failure to find any of the latter enzymatic activity in the serum of Case 1, therefore, afforded no proof of the nature of the metabolic anomaly. Observations of patients with infective hepatitis, however, yielded some indirect evidence. Measurements of aldolase activity in the serum of such cases showed not only a marked rise in activity towards the fructose-I :6-diphosphate, but also the appearance of a high activity towards fructose-l-phosphate. The relative activities towards the two substrates become, at the height of the disease, very similar to the relative activities of liver aldolase. In Cases 1 and 3, during the period when the liver function tests, including the transaminases, showed a marked impairment and the rise in serum fructose-1 :6-diphosphate aldolase activity was similar to that found in infective hepatitis, there was no comparable rise in fructose-l-phosphate aldolase activity. Although this is a negative result, nevertheless it suggests strongly that the liver fructose-lphosphate aldolase activity was, in her case, deficient.
In Case 3 the correctness of the hypothesis of Froesch et al. (1959) was shown by a direct estimation of the liver aldolase activities. There was a difference, however, in the reduction of activities of the two substrates, that to fructose-I :6-diphosphate being reduced to about 16% of the value in a liver specimen in which the enzyme was also determined within one hour of removal, whereas that to fructose-l-phosphate was much more affected, being nearly zero (Table 3) . Similar results were obtained by Hers and Joassin (1961) in two infants with the same condition, except that in the present case the liver aldolase activity to fructose-l-phosphate was reduced to an even lower level, with a ratio of activity to the two substrates of over 20, a value similar to that of muscle aldolase, whereas the ratio given by Hers and Joassin (1961) was only 6-2. In one of the cases of Nikkilii et al. (1962) the level of activity to fructose-l-phosphate was also zero, although their second case showed higher values. The finding of a normal level of fructokinase in the liver of the affected infant showed that the ability to convert fructose to fructose-l-phosphate was unimpaired.
Carbohydrate Metabolism. The striking fall in blood glucose which accompanies ingestion of fructose in these cases was first noted by Froesch et al. (1957) and is characteristic of all the cases described. It does not appear to be due to the high blood fructose level itself since in benign fructosuria there is only a relatively slight fall in blood glucose when fructose is given (Sachs, Sternfeld and Kraus, 1942) . Dubois et al. (1961) Froesch et al. (1959) have shown that fructose-l -phosphatecaninhibitthe action of aldolase on fructose-diphosphate, and Sidbury (1957 Sidbury ( , 1959 has shown that excessive concentrations of galactose-1-phosphate and fructose-I-phosphate can inhibit phosphoglucomutase (Fig. 1) . On the other hand, Nikkila et al. (1962) could find no inhibitory action of fructose-i-phosphate on phosphorylase, phosphoglucomutase or glucose-6-phosphatase (Fig. 1) . Another explanation, not suggested previously, is that the fixation of available phosphate as fructose-1-phosphate could hinder the conversion of glycogen to glucose, which requires the presence of reactive phosphate. In either case, the continued utilization of glucose by the peripheral tissues, together with the failure of mobilization of glycogen by the liver, could account for the observed immediate drop of blood glucose.
That sorbose fails to provoke a hypoglycaemic reaction ) is confirmed in our cases. Since the metabolic pathways of sorbose and fructose are identical so far as the formation of trioses, these authors have concluded that the enzymatic defect may be beyond this point. Since the anomaly is now proved to be a deficiency of aldolase, this explanation must be incorrect. It may be that the aldolase activity to sorbose-l-phosphate is not so impaired as it is to fructose-l-phosphate or that the sorbose-l-phosphate does not inhibit phosphoglucomutase and, therefore, there is no block in the conversion of glycogen to glucose.
Plasma Magnesium. The effect of fructose ingestion on the level of plasma magnesium has not been observed previously. Whilst the drop in plasma phosphorus can be explained by the normal conversion of fructose to fructose-l-phosphate, it is not so easy to account for the increase in plasma magnesium. It does not appear to be due to alterations in the blood level of glucose since an intravenous injection of glucose into a normal child, sufficient to raise the blood glucose from 85 mg. to 340 mg. per 100 ml. in 15 minutes, with a fall to the initial level in a further 30 minutes, failed to alter the plasma magnesium from a level of 2-0 mg. per 100 ml. by more than 0 1 mg. per 100 ml. and this actually was a fall rather than a rise, although the serum phosphorus fell from 4 2 to 3-8 mg. per 100 ml. over the same period. The rise in plasma magnesium is probably directly connected with the block in the cleavage of fructose-l-phosphate. The phosphorylation of fructose requires magnesium ions as well as ATP and Hers (1957) has shown that these two form a complex, ATP-Mg which reacts with the fructose to form adenosine diphosphate (ADP) and magnesium. In fructosaemia, owing to the enzymatic block, the reaction does not proceed further, so that an excess of magnesium could diffuse out of the liver cells into the interstitial fluid and into the plasma. The rise in plasma magnesium could result in renal loss, with a constant drain on magnesium so long as fructose is ingested, and this would finally lead to a low level of plasma magnesium, as was observed in Case 1 before treatment. The depletion of intracellular ATP would result in cellular disturbances. How rapid this can be is shown by the effect of the ingestion of 8 g. fructose on the serum transaminases in Case 3. They rose to five times the fasting level 90 minutes after fructose administration (Table 1) . This disturbance might apply not only to liver cells, but also to the cells of the brain and kidney where fructose is utilized, and could account for the renal manifestations such as aminoaciduria, and for the impairment of liver function. A similar suggestion has been put forward to account for some of the toxic manifestations of galactosaemia (Isselbacher, 1960) and receives some support from the observations of Penington and Prankerd (1958) who found that the ATP content of the red cells of a patient suffering from galactosaemia decreased when he was placed on a lactose diet.
Fructosaemia and Galactosaemia. The close similarity in the clinical and biochemical features of fructosaemia and galactosaemia led us to investigate the effects of galactose ingestion on the plasma levels of glucose, phosphorus and magnesium in galactosaemic patients. Two sibs aged 3 and 4 years, known to have galactosaemia, were investigated, and the results from one of them are shown in Fig. 7 . The fall in blood glucose was not so striking as in the cases of fructosaemia, in neither instance being more than 25 mg. per 100 ml. The fall in plasma phosphorus and the rise in plasma magnesium were of the same order, however, as in the cases of fructosaemia. This further supports the suggestion that the depletion of intracellular ATP could be a cause of some of the toxic manifestations found in the two conditions.
In benign fructosuria, where the metabolic defect probably lies in the failure to convert fructose to fructose-l-phosphate, no alteration in plasma magnesium would be expected with fructose ingestion. Unfortunately, no such case was available for trial. However, impaired tolerance of fructose and galactose in cases of general liver dysfunction is also probably due to a deficiency in the initial stage of hexose phosphorylation, a stage which is similar in the metabolism of both sugars and which will be most stressed. A galactose tolerance test was, therefore, undertaken in an infant of 6 months (Y.G.) in whom the serum transaminases were greatly increased, and both fructose and galactose tolerance were markedly impaired. The total sugar, glucose, phosphorus and magnesium levels in the plasma were determined (Fig. 8 ). There was a marked rise in total blood sugar and a moderate rise in glucose. The plasma phosphorus fell only slightly, indicating that there was an impairment of initial phosphorylation. The level of plasma magnesium was unaltered throughout, indicating that the rise in the level found in fructosaemia and galactosaemia is associated with the block in the second stage in the metabolism of the sugar. It is interesting to note that despite the impaired carbohydrate tolerance tests, the levels of activities of both fructokinase and aldolase in the liver appeared normal. Genetics. A review of the 16 cases described, including the three now reported, clearly confirms the suggestion that the condition is inherited as an autosomal recessive trait. Of the eight families involved, in only one instance was there a history of a parent being affected, whereas in four families, a sib has been found with the same condition. Consanguinity in parents was noted in the cases described by Froesch et al. (1957) and in one other family. The condition is not sex-linked as both females and males are affected, although with a preponderance of the former. Summary Three cases, two sibs and an infant of an unrelated family are described with fructosaemia, an inherited disorder of fructose metabolism.
A review of the 16 cases so far reported, including the present ones, shows that the younger age-group presents as failure to thrive, with vomiting and anorexia, hepatomegaly and hypoglycaemic attacks, following weaning from the breast. The older age-group is often symptomless, but with a marked aversion to sweetened foods. It is concluded that the defect is inherited as an autosomal recessive trait.
Measurements on a biopsy specimen of the liver from one of the three cases confirm that the underlying enzyme defect is an almost complete absence of liver aldolase activity to fructose-l-phosphate, with a markedly reduced activity to fructose-1:6-diphosphate. 
ARCHIVES OF DISEASE IN CHILDHOOD
The effect of the anomaly on carbohydrate metabolism is discussed. The severe hypoglycaemia found when fructose is ingested is not due to insulin response to high levels of fructose, but may result from the reduction in available intracellular phosphate by the accumulation of the blocked fructose-Iphosphate. The ingestion of fructose results also in a decrease in the plasma phosphorus and an increase of plasma magnesium. It is postulated that both may be due to the consumption of ATPMg complex to form fructose-l-phosphate, ADP and free magnesium. The depletion of ATP, it is suggested, may be responsible for some general cellular disturbances and toxic manifestations. Similar changes were found after oral galactose in two cases of galactosaemia, and the clinical and biochemical similarity and the differentiation between this condition and fructosaemia are discussed.
In view of the possibility of physical and mental retardation in untreated cases, the importance of early diagnosis is stressed.
